A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma

Elevated levels of apoB-100 containing lipoproteins and markers of systemic inflammation are often observed in patients with cardiovascular diseases. The concentrations can be reduced by pharmacotherapy or extracorporeal treatment. The sorbent, which removes CRP and atherogenic lipoproteins, simulta...

Descripción completa

Detalles Bibliográficos
Autores principales: Dmitrieva, O. A., Ovchinnikova, E. D., Utkina, E. A., Levashov, P. A., Afanasieva, O. I., Adamova, I. Y., Pokrovsky, S. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807530/
https://www.ncbi.nlm.nih.gov/pubmed/35127146
http://dx.doi.org/10.32607/actanaturae.11292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807530/
https://www.ncbi.nlm.nih.gov/pubmed/35127146
http://dx.doi.org/10.32607/actanaturae.11292

Ejemplares similares